This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Further information

TOLERANCE
Loading...

Mazariegos, George V


Publications

Impact Factor

Cites


ReferenceImpact FactorCitesQuartile
Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, McMichael J, Fung JJ, Starzl TE. Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997 Jan 27;63(2):243-9. PubMed PMID: 9020325; PubMed Central PMCID: PMC3005336.
4.546
304
1
Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant. 2003 Jun;3(6):689-96. PubMed PMID: 12780560.
7.338
131
1
Tokita D, Mazariegos GV, Zahorchak AF, Chien N, Abe M, Raimondi G, Thomson AW. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation. 2008 Feb 15;85(3):369-77. doi: 10.1097/TP.0b013e3181612ded. PubMed PMID: 18301333.
4.546
124
1
Mazariegos GV, Zahorchak AF, Reyes J, Chapman H, Zeevi A, Thomson AW. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant. 2005 Feb;5(2):314-22. PubMed PMID: 15643991.
7.338
82
1
Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol. 2007 Feb;17(2):114-9. Epub 2006 Oct 17. Review. PubMed PMID: 17306742.
1.624
69
3
Feng S, Bucuvalas JC, Mazariegos GV, Magee JC, Sanchez-Fueyo A, Spain KM, Lesniak A, Kanaparthi S, Perito E, Venkat VL, Burrell BE, Alonso EM, Bridges ND, Doo E, Gupta NA, Himes RW, Ikle D, Jackson AM, Lobritto SJ, Jose Lozano J, Martinez M, Ng VL, Rand EB, Sherker AH, Sundaram SS, Turmelle YP, Wood-Trageser M, Demetris AJ. Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Towards Personalized Management. Hepatology. 2020 Aug 12. doi: 10.1002/hep.31520. [Epub ahead of print] PubMed PMID: 32786149.
14.679
48
1
Castellaneta A, Mazariegos GV, Nayyar N, Zeevi A, Thomson AW. HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance. Transplantation. 2011 May 27;91(10):1132-40. doi: 10.1097/TP.0b013e31821414c9. PubMed PMID: 21423069; PubMed Central PMCID: PMC3087844.
4.546
47
1
Mazariegos GV, Reyes J, Webber SA, Thomson AW, Ostrowski L, Abmed M, Pillage G, Martell J, Awad MR, Zeevi A. Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation. 2002 Apr 27;73(8):1342-5. PubMed PMID: 11981433.
4.546
34
1
Girnita A, Mazariegos GV, Castellaneta A, Reyes J, Bentlejewski C, Thomson AW, Zeevi A. Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies. Hum Immunol. 2010 Mar;71(3):274-6. doi: 10.1016/j.humimm.2009.12.002. Epub 2009 Dec 23. PubMed PMID: 20006667.
2.412
33
3
Thomson AW, Mazariegos GV, Reyes J, Donnenberg VS, Donnenberg AD, Bentlejewski C, Zahorchak AF, O'Connell PJ, Fung JJ, Jankowska-Gan E, Burlingham WJ, Heeger PS, Zeevi A. Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation. 2001 Oct 27;72(8 Suppl):S13-22. Review. PubMed PMID: 11888150.
4.546
28
1
Castellaneta A, Thomson AW, Nayyar N, de Vera M, Mazariegos GV. Monitoring the operationally tolerant liver allograft recipient. Curr Opin Organ Transplant. 2010 Feb;15(1):28-34. doi: 10.1097/MOT.0b013e328334269a. Review. PubMed PMID: 19890211.
2.571
19
3
Sindhi R, Ganjoo J, McGhee W, Mazariegos G, Reyes J. Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants. Transplant Proc. 2002 Aug;34(5):1972-3. PubMed PMID: 12176651.
0.784
18
4
Mazariegos GV. Immunosuppression withdrawal after liver transplantation: what are the next steps? Transplantation. 2011 Apr 15;91(7):697-9. doi: 10.1097/TP.0b013e31820c85a3. PubMed PMID: 21293321.
4.546
16
1
Mazariegos GV. Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD. Pediatr Transplant. 2004 Jun;8(3):210-3. PubMed PMID: 15176955.
1.425
8
3
Kortbeek S, Anderson SG, Alonso EM, Rand EB, Bucuvalas J, Mazariegos GV, Campbell KM, Lobritto SJ, Feldman AG, Mysore KR, Anand R, Selzner N, Ng VL; SPLIT Registry. Immunosuppression-Free Life after Pediatric Liver Transplant: A Case-Control Study from the Society of Pediatric Liver Transplant (SPLIT) Registry. J Pediatr. 2023 Sep 17:113744. doi: 10.1016/j.jpeds.2023.113744. Online ahead of print. PubMed PMID: 37726087.
5.1
0
Shemesh E, Anand R, Annunziato RA, Fredericks EM, Garcia J, Gupta NA, Kleinman LC, Kriegermeier A, Mysore KR, Ng VL, Lobritto SJ, Patel S, Perito ER, Rand EB, Romero R, Venick RS, Duncan-Park S, Mitchell J, Anderson SG, Stuber ML, Reyes-Mugica M, Mazariegos GV, Shneider BL. A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipients. Am J Transplant. 2026 May 27:S1600-6135(26)00238-8. doi: 10.1016/j.ajt.2026.04.030. Online ahead of print. PubMed PMID: 42208859.
8.2
Abu-Elmagd K, Fung J, Todo S, Rao A, Reyes J, Demetris J, Mazariegos G, Fontes P, McMichael J, Furukawa H, et al. The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl. 1995:145-70. Review. PubMed PMID: 8794262; PubMed Central PMCID: PMC2987661.
4.593

Data Sources

PubMed
NCBI
SemanticScholar
Web of Science
Human Phenotype ontology
KEGG
IMIB-Arrixaca

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain

E-mail

Phones

+34 968885229
+34 968885239
+34 968885249

Advanced Charts